Advancing breath biomarkers for detection of Plasmodium falciparum infection

This study prospectively evaluates breath volatile biomarkers of pediatric Plasmodium falciparum malaria in an independent cohort in Blantyre, Malawi. Building on prior work that identified characteristic changes in volatile emissions from cultured P. falciparum and in naturally infected humans, the investigators enrolled febrile children under evaluation for malaria as well as healthy controls and collected expiratory breath samples to characterize malaria-associated volatile organic compounds (VOCs). The study used gas chromatography/mass spectrometry to profile targeted and untargeted breath volatiles, and incorporated repeated sampling of children with malaria before and after antimalarial therapy to determine how breath profiles change in response to treatment. The cohort comprised 115 participants tested by smear and rapid diagnostic test (RDT), with additional quantitative polymerase chain reaction (qPCR) testing that reassigned five smear/RDT-negative participants to the P. falciparum-infected group. The investigators also examined correlations between breath biomarkers and parasitemia, exploring potential stage-specificity by comparing associations with asexual and sexual parasite stages.

Results from the study provide robust evidence that P. falciparum infection produces specific, reproducible alterations in breath VOCs. While the authors note that no single compound served as an adequate classifier on its own, combinations of selected volatiles yielded high sensitivity for diagnosing malaria. Predictive models developed from the breath profiles suggest reproducible volatile signatures that distinguish infected from uninfected children and that moreover reflect the response to antimalarial therapy. Notably, these breath signatures were detectable even in cases of low parasitemia, indicating potential utility for noninvasive detection across a range of infection intensities. Visualizations such as linear discriminant analysis score plots and heatmaps of candidate VOCs illustrate separation between infected, uninfected febrile, and healthy control groups based on breath profiles. The study design emphasizes reproducibility and clinical relevance: an independent pediatric cohort in Malawi; standardized breath collection paired with diagnostic testing (smear, RDT, qPCR); analytical characterization of volatiles via GC/MS; and longitudinal sampling to observe dynamics with therapy.

By demonstrating that breath VOC signatures reproducibly associate with P. falciparum infection status and respond to antimalarial treatment, this work advances the concept of breath-based diagnostics for malaria. The findings support further development of breath-based approaches that combine multiple volatiles into predictive models, with potential applications in noninvasive screening, monitoring therapy response, and detection of low-density infections. The reproducibility observed in this independent pediatric cohort strengthens evidence for breath biomarkers as a promising avenue for diagnostic innovation in malaria-endemic settings.